Literature DB >> 30892546

Rheumatic heart disease in the modern era: recent developments and current challenges.

Matheus Tozatto Baptista Coelho Leal1, Livia Silva Araújo Passos1,2, Felipe Vieira Guarçoni1, João Marcelo de Souza Aguiar1, Rafael Benjamim Rosa da Silva1, Thiago Mendonça Nunes de Paula1, Rafael Figueiredo Dos Santos1, Maria Cecília Landim Nassif1, Nayana F A Gomes1, Timothy C Tan3, Maria Carmo Pereira Nunes1.   

Abstract

Rheumatic heart disease (RHD) remains a major cause of preventable death and disability in children and young adults. Despite significant advances in medical technology and increased understanding of disease mechanisms, RHD continues to be a serious public health problem throughout the world, especially in low- and middle-income countries. Echocardiographic screening has played a key role in improving the accuracy of diagnosing RHD and has highlighted the disease burden. Most affected patients present with severe valve disease and limited access to life-saving cardiac surgery or percutaneous valve intervention, contributing to increased mortality and other complications. Although understanding of disease pathogenesis has advanced in recent years, key questions remain to be addressed. Preventing or providing early treatment for streptococcal infections is the most important step in reducing the burden of this disease.

Entities:  

Mesh:

Year:  2019        PMID: 30892546     DOI: 10.1590/0037-8682-0041-2019

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  11 in total

1.  Surgical Treatment of Valvular Heart Disease in Nigeria: A 6-Year Experience.

Authors:  Ikechukwu A Nwafor; John C Eze; Maureen N Nwafor
Journal:  Tex Heart Inst J       Date:  2021-11-01

2.  Systemic cytokines, chemokines and growth factors reveal specific and shared immunological characteristics in infectious cardiomyopathies.

Authors:  Eula G A Neves; Carolina C Koh; José L Padilha da Silva; Lívia S A Passos; Fernanda N A Villani; Janete S C Dos Santos; Cristiane A S Menezes; Vicente R Silva; Julia P A S Tormin; Guilherme F B Evangelista; Andréa Teixeira de Carvalho; Manoel Otávio da Costa Rocha; Bruno Nascimento; Kenneth John Gollob; Maria do Carmo P Nunes; Walderez O Dutra
Journal:  Cytokine       Date:  2021-09-27       Impact factor: 3.861

3.  Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50-70 Years.

Authors:  Jun Yu; Wei Wang
Journal:  Front Cardiovasc Med       Date:  2022-05-31

4.  Prevalence of rheumatic heart disease among school children in East Africa: a systematic review and meta-analysis.

Authors:  Melaku Bimerew; Biruk Beletew; Addisu Getie; Adam Wondmieneh; Getnet Gedefaw; Asmamaw Demis
Journal:  Pan Afr Med J       Date:  2021-03-08

5.  Progression of Mitral Regurgitation in Rheumatic Valve Disease: Role of Left Atrial Remodeling.

Authors:  Nayana F A Gomes; Vicente Rezende Silva; Robert A Levine; William A M Esteves; Marildes Luiza de Castro; Livia S A Passos; Jacob P Dal-Bianco; Alexandre Negrão Pantaleão; Jose Luiz Padilha da Silva; Timothy C Tan; Walderez O Dutra; Elena Aikawa; Judy Hung; Maria Carmo P Nunes
Journal:  Front Cardiovasc Med       Date:  2022-03-11

Review 6.  Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders.

Authors:  Akylbek Sydykov; Argen Mamazhakypov; Abdirashit Maripov; Djuro Kosanovic; Norbert Weissmann; Hossein Ardeschir Ghofrani; Akpay Sh Sarybaev; Ralph Theo Schermuly
Journal:  Int J Environ Res Public Health       Date:  2021-02-10       Impact factor: 3.390

Review 7.  Insights Into the Involvement of Circular RNAs in Autoimmune Diseases.

Authors:  Xingyu Zhai; Yunfei Zhang; Shuyu Xin; Pengfei Cao; Jianhong Lu
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 8.  Signalling pathways implicated in the pathogenesis of rheumatic heart disease (Review).

Authors:  Shenglin Xian; Zhiyu Zeng
Journal:  Exp Ther Med       Date:  2020-11-25       Impact factor: 2.447

9.  Altered Expression of Transfer-RNA-Derived Small RNAs in Human With Rheumatic Heart Disease.

Authors:  Zhao-Yu Yang; Peng-Fei Li; Zhi-Qing Li; Tao Tang; Wei Liu; Yang Wang
Journal:  Front Cardiovasc Med       Date:  2021-12-01

10.  Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease.

Authors:  Shenglin Xian; Ang Chen; Yunjiao Wu; Hong Wen; Chuanghong Lu; Feng Huang; Zhiyu Zeng
Journal:  Int J Mol Med       Date:  2021-07-23       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.